Skip to main content
Log in

Circulating levels of vasoactive peptides in patients with acute bacterial meningitis

  • BRIEF REPORT
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

The underlying mechanisms for cerebral blood flow (CBF) abnormalities in acute bacterial meningitis (ABM) are largely unknown. Putative mediators include vasoactive peptides, e.g. calcitonin-gene related peptide (CGRP), vasoactive intestinal peptide (VIP), and endothelin-1 (ET-1), all of which may be affected by therapeutic interventions used in the intensive care unit. We measured arterial levels as well as the net cerebral flux of these peptides in patients with ABM, and in healthy volunteers undergoing interventions relevant to intensive care.

Methods

Seven patients with severe ABM and sepsis and fifteen healthy volunteers were included after informed consent. The net cerebral fluxes of vasoactive peptides were measured by the Kety-Schmidt technique in ABM patients (baseline study only), as well as in volunteers at baseline, during voluntary hyperventilation, after an intravenous injection of lipopolysaccharide (LPS), and during norepinephrine infusion.

Results

The arterial levels of CGRP, but not of VIP or ET-1, were elevated in patients with ABM, but no net cerebral flux was present. CGRP levels decreased during hyperventilation and after LPS injection. No net cerebral flux of VIP occurred in any group at any time. A cerebral efflux of ET-1, which occurred in volunteers at baseline, was neither present in volunteers after LPS injection nor in patients with ABM.

Conclusion

The arterial concentration of the vasodilatory peptide, CGRP, but of neither VIP nor the vasoconstrictor ET-1, is elevated in patients with ABM and sepsis. A constitutive cerebral output of ET-1 appears to be present in healthy humans, but is abolished after LPS injection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Scheld WM, Koedel U, Nathan B, Pfister HW (2002) Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 186(Suppl 2):S225–S233

    Article  PubMed  CAS  Google Scholar 

  2. Pfister LA, Tureen JH, Shaw S, Christen S, Ferriero DM, Täuber MG, Leib SL (2000) Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol 47:329–335

    Article  PubMed  CAS  Google Scholar 

  3. Uddman R, Edvinsson L (1989) Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev 1:230–252

    PubMed  CAS  Google Scholar 

  4. Hoffmann O, Keilwerth N, Bille MB, Reuter U, Angstwurm K, Schumann RR, Dirnagl U, Weber JR (2002) Triptans reduce the inflammatory response in bacterial meningitis. J Cereb Blood Flow Metab 22:988–996

    Article  PubMed  CAS  Google Scholar 

  5. Brandtzaeg P, Oktedalen O, Kierulf P, Opstad PK (1989) Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul Pept 24:37–44

    Article  PubMed  CAS  Google Scholar 

  6. Koedel U, Gorriz C, Lorenzl S, Pfister HW (1997) Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clin Infect Dis 25:329–330

    Article  PubMed  CAS  Google Scholar 

  7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655

    Article  PubMed  CAS  Google Scholar 

  8. Møller K, Strauss GI, Qvist J, Fonsmark L, Knudsen GM, Larsen FS, Krabbe KS, Skinhøj P, Pedersen BK (2002) Cerebral blood flow and oxidative metabolism during human endotoxemia. J Cereb Blood Flow Metab 22:1262–1270

    Article  PubMed  Google Scholar 

  9. Møller K, Qvist T, Tofteng F, Sahl C, Sønderkær S, Dethloff T, Knudsen GM, Larsen FS (2004) Cerebral blood flow and metabolism during infusion of norepinephrine and propofol in patients with bacterial meningitis. Stroke 35:1333–1339

    Article  PubMed  Google Scholar 

  10. Schifter S (1991) Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassay. Peptides 12:365–369

    Article  PubMed  CAS  Google Scholar 

  11. Fahrenkrug J, Schaffalitzky de Muckadell OV (1977) Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med 89:1379–1388

    PubMed  CAS  Google Scholar 

  12. Fick A (1870) Über die Messung des Blutquantums in den Herzventrikeln. Verh Phys Med Ges Würzburg 2:16

    Google Scholar 

  13. Arnalich F, Hernanz A, Jimenez M, Lopez J, Tato E, Vazquez JJ, Montiel C (1996) Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul Pept 65:115–121

    Article  PubMed  CAS  Google Scholar 

  14. Beer S, Weighardt H, Emmanuilidis K, Harzenetter MD, Matevossian E, Heidecke CD, Bartels H, Siewert JR, Holzmann B (2002) Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 30:1794–1798

    Article  PubMed  CAS  Google Scholar 

  15. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B (2004) Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32:1715–1721

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Supported by grants from The Foundation in Commemoration of Holger and Ruth Hesse, The Foundation for Clinical Research in Copenhagen Hospital Corporation, The AP Møller Foundation, The Larsen Foundation, The Skovgaard Foundation, The Hørslev Foundation, The University of Copenhagen, The Danish National Health Research Council, The Laerdal Foundation, The Maigaard Foundation, The Novo Nordisk Foundation, The P. Carl Pedersen Foundation, and The Gangsted Foundation. The Centre of Inflammation and Metabolism is supported by grants from the Danish National Research Foundation (DG 02-512-555) and the Commission of the European Communities (contract no. LSHM-CT-2004-005272 EXGENESIS).

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronan M. G. Berg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berg, R.M.G., Strauss, G.I., Tofteng, F. et al. Circulating levels of vasoactive peptides in patients with acute bacterial meningitis. Intensive Care Med 35, 1604–1608 (2009). https://doi.org/10.1007/s00134-009-1515-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-009-1515-3

Keywords

Navigation